Get the Stockscreener App
182.33
0.54%
-1.075
Overview
News
Price History
Option Chain
Financials
Why BDX Down?
Discussions
Forecast
Stock Split
Dividend History
Becton Dickinson Co stock is traded at $182.33, with a volume of 585.28K.
It is down -0.54% in the last 24 hours and up +15.33% over the past month.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
See More
Previous Close:
$183.40
Open:
$181.89
24h Volume:
585.28K
Relative Volume:
0.25
Market Cap:
$49.66B
Revenue:
$21.37B
Net Income/Loss:
$1.41B
P/E Ratio:
46.23
EPS:
3.9437
Net Cash Flow:
$3.07B
1W Performance:
+1.55%
1M Performance:
+15.33%
6M Performance:
+2.84%
1Y Performance:
-6.90%
1-Day Range:
$181.62
$183.46
1-Week Range:
$177.13
$185.32
52-Week Range:
$140.11
$213.08
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson Co
Sector
Industry
Phone
(201) 847-6800
Address
ONE BECTON DR, FRANKLIN LAKES
Compare BDX vs ISRG, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
182.33 | 49.96B | 21.37B | 1.41B | 3.07B | 3.9437 |
ISRG
Intuitive Surgical Inc
|
390.62 | 139.37B | 11.03B | 3.16B | 3.22B | 8.7251 |
ALC
Alcon Inc
|
72.61 | 35.89B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
220.37 | 32.38B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
34.66 | 31.36B | 29.14B | 1.07B | 1.05B | 1.1956 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-26 | Resumed | Goldman | Neutral |
| Feb-10-26 | Resumed | Barclays | Overweight |
| Feb-03-26 | Resumed | Citigroup | Buy |
| Sep-25-25 | Initiated | RBC Capital Mkts | Sector Perform |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| May-02-25 | Downgrade | Goldman | Buy → Neutral |
| May-02-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-02-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-01-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-01-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-24-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| May-05-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-12-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-03-23 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-12-22 | Upgrade | Citigroup | Sell → Neutral |
| Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
| Jun-24-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-22 | Resumed | Raymond James | Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-09-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-01-20 | Resumed | Goldman | Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-07-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-07-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-07-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Feb-06-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-08-20 | Downgrade | Barclays | Overweight → Equal Weight |
| May-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-07-18 | Initiated | Deutsche Bank | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Jun-21-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-10-18 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-18 | Resumed | BofA/Merrill | Buy |
| Jan-05-18 | Upgrade | Citigroup | Sell → Neutral |
| Jan-05-18 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Dec-29-17 | Reiterated | Deutsche Bank | Buy |
View All
Becton Dickinson Co Stock (BDX) Latest News
SFE Investment Counsel Invests $2.67 Million in Becton, Dickinson and Company $BDX - MarketBeat
Bryn Mawr Trust Advisors LLC Purchases Shares of 46,332 Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson (BDX) CEO exercises 43,278 SARs and disposes shares under 10b5-1 plan - Stock Titan
Becton, Dickinson: An Earnings Beat Again As Diverse Clinical Portfolio Keeps On Growing - Seeking Alpha
Medline Convenience Kits Impacted By Contamination In Recalled Becton Dickinson Products - Benzinga
Becton Dickinson EVP Roland Goette sells $440,887 in stock - Investing.com
Citigroup Adjusts Price Target on Becton Dickinson and Co. to $208 From $204, Maintains Buy Rating - marketscreener.com
RBC Adjusts PT on Becton Dickinson and Co. to $190 From $180, Keeps Sector Perform Rating - marketscreener.com
Becton, Dickinson and Company $BDX Shares Purchased by Handelsbanken Fonder AB - MarketBeat
Becton Dickinson and Co (BDX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Becton Dickinson & Co Insider Sold Shares Worth $440,888, According to a Recent SEC Filing - marketscreener.com
Becton Dickinson (NYSE: BDX) EVP Roland Goette sells 2,438 shares at $180.84 - Stock Titan
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
UBS Adjusts Becton Dickinson and Co. PT to $205 From $190, Maintains Buy Rating - marketscreener.com
UBS Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Raises Target Price to $205 - Moomoo
Becton, Dickinson and Company $BDX Shares Purchased by Northside Capital Management LLC - MarketBeat
BD Accelerates Advanced Tissue Regeneration Strategy with Landmark PREVENT Trial – Company Announcement - Financial Times
Cardinal Capital Management Inc. Has $27 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson (BDX) Is Up 6.6% After Strong Q3 And Higher 2026 Outlook Has The Bull Case Changed? - simplywall.st
First Eagle Investment Buys Becton Dickinson & Co (BDX) -- Shares Look 6% Undervalued on GF Value - GuruFocus
J.P. Morgan Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $188 - Moomoo
NewEdge Advisors LLC Acquires 11,414 Shares of Becton, Dickinson and Company $BDX - MarketBeat
BD Earnings Call: Solid Beat, Guidance Raised - The Globe and Mail
Becton, Dickinson and Company (BDX) Stock forecasts - Yahoo Finance UK
Becton Dickinson & Co. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Becton, Dickinson and Company (BDX) Stock Analysis: Exploring Growth Potential and Dividend Stability - directorstalkinterviews.com
Avity Investment Management Inc. Sells 18,213 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Royal Bank Of Canada Upgrades Becton, Dickinson and Company (NYSE:BDX) to Hold - MarketBeat
JPMorgan Adjusts Price Target on Becton Dickinson and Co. to $188 From $175 - Moomoo
Becton Dickinson & Co (BDX) (Q3 2026) Earnings Call Highlights: - GuruFocus
Becton Dickinson & Co (BDX) (Q3 2026) Earnings Call Highlights: Strong Revenue Growth and ... - finance.yahoo.com
Becton Dickinson Is Maintained at Buy by Citigroup - Moomoo
Becton, Dickinson and Company (NYSE:BDX) Given New $204.00 Price Target at Citigroup - MarketBeat
Becton, Dickinson's Fiscal Q3 Results Show Progress Amid Major Headwinds, RBC Says - Moomoo
Can Becton Dickinson (NYSE:BDX) Strengthen Its Medtech Story? - Kalkine Media
Becton, Dickinson and Company (NYSE:BDX) Price Target Raised to $175.00 at Piper Sandler - MarketBeat
Wells Fargo Adjusts Price Target on Becton Dickinson and Co. to $170 From $161 - marketscreener.com
Jefferies Adjusts Price Target on Becton Dickinson and Co. to $210 From $190 - marketscreener.com
Citigroup Adjusts Price Target on Becton Dickinson and Co. to $204 From $198 - marketscreener.com
RBC Capital Initiates Becton Dickinson & Co(BDX.US) With Hold Rating, Announces Target Price $180 - 富途牛牛
Becton, Dickinson and Company (NYSE:BDX) Price Target Raised to $170.00 at Wells Fargo & Company - MarketBeat
Stifel Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Raises Target Price to $195 - 富途牛牛
RBC Adjusts PT on Becton Dickinson and Co. to $180 From $175, Maintains Sector Perform Rating - marketscreener.com
Becton, Dickinson and Co (BOX.MU) Analyst insights, Price targets and Recommendations - Yahoo Finance Australia
Becton Dickinson and Co (BDX) Stock News Today - TradingKey
Becton, Dickinson and Company (NYSE:BDX) Announces Earnings Results - MarketBeat
Becton Dickinson & Co (BDX) Stock Up 3.8% and Still Undervalued -- GF Score: 76/100 - GuruFocus
Becton Dickinson 3Q FY2026: Revenue $5B, EPS $1.37— 10-Q Summary - TradingView
Becton Dickinson (NYSE: BDX) director awarded 189 deferred stock rights - Stock Titan
Becton Dickinson (NYSE: BDX) director awarded deferred stock rights - Stock Titan
[10-Q] BECTON DICKINSON & CO Quarterly Earnings Report - Stock Titan
Becton Dickinson Co Stock (BDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):